When is HROW's latest earnings report released?
The most recent financial report for Harrow health, inc. (HROW) covers the period of 2025Q3 and was published on 2025/09/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating HROW's short-term business performance and financial health. For the latest updates on HROW's earnings releases, visit this page regularly.
What is the operating profit of HROW?
According to the latest financial report, Harrow health, inc. (HROW) reported an Operating Profit of 14.75M with an Operating Margin of 20.59% this period, representing a growth of 1,016.35% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.
How is HROW's revenue growth?
In the latest financial report, Harrow health, inc. (HROW) announced revenue of 71.64M, with a Year-Over-Year growth rate of 45.44%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.
How much debt does HROW have?
As of the end of the reporting period, Harrow health, inc. (HROW) had total debt of 251.87M, with a debt ratio of 0.69. Long-term debt comprises a higher/lower proportion. The level of financial leverage directly impacts the company's capital structure and interest coverage. If debt is high, pay attention to interest expenses and refinancing risks. Conversely, a low-leverage structure indicates greater risk tolerance but potentially less growth flexibility.
How much cash does HROW have?
At the end of the period, Harrow health, inc. (HROW) held Total Cash and Cash Equivalents of 74.29M, accounting for 0.2 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.
Does HROW go with three margins increasing?
In the latest report, Harrow health, inc. (HROW) achieved the “three margins increasing” benchmark, with a gross margin of 75.3%%, operating margin of 20.59%%, and net margin of 1.4%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess HROW's profit trajectory and future growth potential.
Is HROW's EPS continuing to grow?
According to the past four quarterly reports, Harrow health, inc. (HROW)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at 0.03. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.
What is the FCF of HROW?
Harrow health, inc. (HROW)'s Free Cash Flow (FCF) for the period is 16.38M, calculated as Operating Cash Flow minus Capital Expenditures, representing a rise of 597.83% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.
